Copyright Reports & Markets. All rights reserved.

Global Diabetes Drug Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Diabetes Drug

      • 1.1 Definition of Diabetes Drug
      • 1.2 Diabetes Drug Segment by Type
        • 1.2.1 Global Diabetes Drug Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Insulin
        • 1.2.3 Sensitizers
        • 1.2.4 SGLT-2 Inhibitors
        • 1.2.5 Alpha-glucosidase Inhibitors
        • 1.2.6 Secretagogues
        • 1.2.7 Peptide Analogs
        • 1.2.8 Others
      • 1.3 Diabetes Drug Segment by Applications
        • 1.3.1 Global Diabetes Drug Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.4 Global Diabetes Drug Overall Market
        • 1.4.1 Global Diabetes Drug Revenue (2014-2025)
        • 1.4.2 Global Diabetes Drug Production (2014-2025)
        • 1.4.3 North America Diabetes Drug Status and Prospect (2014-2025)
        • 1.4.4 Europe Diabetes Drug Status and Prospect (2014-2025)
        • 1.4.5 China Diabetes Drug Status and Prospect (2014-2025)
        • 1.4.6 Japan Diabetes Drug Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Diabetes Drug Status and Prospect (2014-2025)
        • 1.4.8 India Diabetes Drug Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Diabetes Drug
      • 2.3 Manufacturing Process Analysis of Diabetes Drug
      • 2.4 Industry Chain Structure of Diabetes Drug

      3 Development and Manufacturing Plants Analysis of Diabetes Drug

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Diabetes Drug Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Diabetes Drug
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Diabetes Drug Production and Capacity Analysis
      • 4.2 Diabetes Drug Revenue Analysis
      • 4.3 Diabetes Drug Price Analysis
      • 4.4 Market Concentration Degree

      5 Diabetes Drug Regional Market Analysis

      • 5.1 Diabetes Drug Production by Regions
        • 5.1.1 Global Diabetes Drug Production by Regions
        • 5.1.2 Global Diabetes Drug Revenue by Regions
      • 5.2 Diabetes Drug Consumption by Regions
      • 5.3 North America Diabetes Drug Market Analysis
        • 5.3.1 North America Diabetes Drug Production
        • 5.3.2 North America Diabetes Drug Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Diabetes Drug Import and Export
      • 5.4 Europe Diabetes Drug Market Analysis
        • 5.4.1 Europe Diabetes Drug Production
        • 5.4.2 Europe Diabetes Drug Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Diabetes Drug Import and Export
      • 5.5 China Diabetes Drug Market Analysis
        • 5.5.1 China Diabetes Drug Production
        • 5.5.2 China Diabetes Drug Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Diabetes Drug Import and Export
      • 5.6 Japan Diabetes Drug Market Analysis
        • 5.6.1 Japan Diabetes Drug Production
        • 5.6.2 Japan Diabetes Drug Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Diabetes Drug Import and Export
      • 5.7 Southeast Asia Diabetes Drug Market Analysis
        • 5.7.1 Southeast Asia Diabetes Drug Production
        • 5.7.2 Southeast Asia Diabetes Drug Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Diabetes Drug Import and Export
      • 5.8 India Diabetes Drug Market Analysis
        • 5.8.1 India Diabetes Drug Production
        • 5.8.2 India Diabetes Drug Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Diabetes Drug Import and Export

      6 Diabetes Drug Segment Market Analysis (by Type)

      • 6.1 Global Diabetes Drug Production by Type
      • 6.2 Global Diabetes Drug Revenue by Type
      • 6.3 Diabetes Drug Price by Type

      7 Diabetes Drug Segment Market Analysis (by Application)

      • 7.1 Global Diabetes Drug Consumption by Application
      • 7.2 Global Diabetes Drug Consumption Market Share by Application (2014-2019)

      8 Diabetes Drug Major Manufacturers Analysis

      • 8.1 Eli Lilly
        • 8.1.1 Eli Lilly Diabetes Drug Production Sites and Area Served
        • 8.1.2 Eli Lilly Product Introduction, Application and Specification
        • 8.1.3 Eli Lilly Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novo Nordisk
        • 8.2.1 Novo Nordisk Diabetes Drug Production Sites and Area Served
        • 8.2.2 Novo Nordisk Product Introduction, Application and Specification
        • 8.2.3 Novo Nordisk Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Abbott
        • 8.3.1 Abbott Diabetes Drug Production Sites and Area Served
        • 8.3.2 Abbott Product Introduction, Application and Specification
        • 8.3.3 Abbott Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 AstraZeneca
        • 8.4.1 AstraZeneca Diabetes Drug Production Sites and Area Served
        • 8.4.2 AstraZeneca Product Introduction, Application and Specification
        • 8.4.3 AstraZeneca Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Biocon
        • 8.5.1 Biocon Diabetes Drug Production Sites and Area Served
        • 8.5.2 Biocon Product Introduction, Application and Specification
        • 8.5.3 Biocon Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Sunpharma
        • 8.6.1 Sunpharma Diabetes Drug Production Sites and Area Served
        • 8.6.2 Sunpharma Product Introduction, Application and Specification
        • 8.6.3 Sunpharma Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Sanofi
        • 8.7.1 Sanofi Diabetes Drug Production Sites and Area Served
        • 8.7.2 Sanofi Product Introduction, Application and Specification
        • 8.7.3 Sanofi Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Novartis
        • 8.8.1 Novartis Diabetes Drug Production Sites and Area Served
        • 8.8.2 Novartis Product Introduction, Application and Specification
        • 8.8.3 Novartis Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Merck
        • 8.9.1 Merck Diabetes Drug Production Sites and Area Served
        • 8.9.2 Merck Product Introduction, Application and Specification
        • 8.9.3 Merck Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Pfizer
        • 8.10.1 Pfizer Diabetes Drug Production Sites and Area Served
        • 8.10.2 Pfizer Product Introduction, Application and Specification
        • 8.10.3 Pfizer Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Daiichi Sankyo
      • 8.12 Boehringer Ingelheim
      • 8.13 Akros Pharma
      • 8.14 Amgen
      • 8.15 Adocia
      • 8.16 Peptron
      • 8.17 Takeda

      9 Development Trend of Analysis of Diabetes Drug Market

      • 9.1 Global Diabetes Drug Market Trend Analysis
        • 9.1.1 Global Diabetes Drug Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Diabetes Drug Regional Market Trend
        • 9.2.1 North America Diabetes Drug Forecast 2019-2025
        • 9.2.2 Europe Diabetes Drug Forecast 2019-2025
        • 9.2.3 China Diabetes Drug Forecast 2019-2025
        • 9.2.4 Japan Diabetes Drug Forecast 2019-2025
        • 9.2.5 Southeast Asia Diabetes Drug Forecast 2019-2025
        • 9.2.6 India Diabetes Drug Forecast 2019-2025
      • 9.3 Diabetes Drug Market Trend (Product Type)
      • 9.4 Diabetes Drug Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Diabetes Drug Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two type of diabetes namely type-1 diabetes and type-2 diabetes. During last decade there is a tremendous increase in the number of diabetic population.
        The analysis shows human insulins and analogues dominated the antidiabetics market in 2017.

        The global Diabetes Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Diabetes Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diabetes Drug market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Diabetes Drug in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Diabetes Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Eli Lilly
        Novo Nordisk
        Abbott
        AstraZeneca
        Biocon
        Sunpharma
        Sanofi
        Novartis
        Merck
        Pfizer
        Daiichi Sankyo
        Boehringer Ingelheim
        Akros Pharma
        Amgen
        Adocia
        Peptron
        Takeda

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Insulin
        Sensitizers
        SGLT-2 Inhibitors
        Alpha-glucosidase Inhibitors
        Secretagogues
        Peptide Analogs
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now